TP53 and cancer: NMTP-5 can activate p53 signaling by targeting NRP1 into the cytoplasm of cancer cells, and at the same time interfere with MDM2-p53 interaction to up-regulate p53 levels and activate the expression of target genes that mediate cell cycle arrest and apoptosis in hepatocellular carcinoma (Zhou et al., 2021).